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 opioid receptor (KOPR)2 is one of the three major types of
opioid receptors mediating effects of opioid drugs and endogenous opioid peptides. Stimulation of KOPR generates many
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effects in vivo, for example antinociception (especially for visceral chemical pain, antipruritis, and water diuresis (1). The
KOPR agonist nalfurafine (TRK-820) is used clinically in Sweden for the treatment of uremic pruritus in kidney dialysis
patients (2). Because KOPR agonists produce profound sedative effects, it has been proposed that KOPR agonists may be
useful in treating mania, antagonists as anti-depressants, and
partial agonists for the management of mania depression (3).
KOPR antagonists may also be useful for curbing cocaine craving and as anti-anxiety drugs (4, 5).
KOPR, a member of the rhodopsin subfamily of the seventransmembrane receptor superfamily, is coupled preferentially
to pertussis toxin-sensitive G proteins, namely Gi/o proteins (6).
KOPR has been found to interact with several non-G proteinbinding partners, such as Na⫹,H⫹-exchanger regulatory factor-1/ezrin-radixin-moesin-binding phosphoprotein-50 and
the ␦ opioid receptor. These interactions have influence on signal transduction and trafficking of the receptor (7–9). By yeast
two-hybrid (Y2H) assay using the hKOPR C-tail to screen a
human brain cDNA library, we identified GEC1, also named
GABAA receptor-associated protein like 1 (GABARAPL1), to
be a binding partner of hKOPR (10).
GEC1 cDNA was first cloned as an early estrogen-regulated
mRNA from guinea pig endometrial glandular epithelial cells
by Pellerin et al. (11). Subsequently, it was cloned from other
species, including human and house mouse (12). Interestingly,
the amino acid sequences of GEC1 are completely conserved
among all these species except orangutan, in which Arg99 substitutes for His99. Northern blot and immunoblotting analyses
revealed that it has widespread tissue distribution (12–14). In
particular, GEC1 was found to be abundant in the central nervous system and expressed throughout the rat brain (14, 15).
This wide tissue distribution and the high sequence identity
across species strongly suggest that GEC1 has important biological functions in mammalian cells.
Based on sequence similarity, GEC1 is classified as a member
of microtubule-associated proteins (MAPs), which also include
GABAA receptor-associated protein (GABARAP), Golgi-associated ATPase enhancer of 16 kDa (GATE16), GABARAP-like
3 (GABARAPL3), light chain 3 (LC3) of MAP 1A/1B, and the
yeast autophagy protein 8 (Atg8) (12, 13). Among these homologues, GEC1 share the highest identity with GABARAPL3
(93%), followed by GABARAP (86%), GATE16 (61%), Atg8
(55%), and LC3 (⬃30%).
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We demonstrated previously that the protein GEC1 (glandular epithelial cell 1) bound to the human  opioid receptor
(hKOPR) and promoted cell surface expression of the receptor by facilitating its trafficking along the secretory pathway.
Here we showed that three hKOPR residues (Phe345, Pro346,
and Met350) and seven GEC1 residues (Tyr49, Val51, Leu55,
Thr56, Val57, Phe60, and Ile64) are indispensable for the interaction. Modeling studies revealed that the interaction was
mediated via direct contacts between the kinked hydrophobic
fragment in hKOPR C-tail and the curved hydrophobic surface in GEC1 around the S2 ␤-strand. Intramolecular Leu44Tyr109 interaction in GEC1 was important, likely by maintaining its structural integrity. Microtubule binding
mediated by the GEC1 N-terminal domain was essential for
the GEC1 effect. Expression of GEC1 also increased cell surface levels of the GluR1 subunit and the prostaglandin EP3.f
receptor, which have FPXXM and FPXM sequences, respectively. With its widespread distribution in the nervous system
and its predominantly hydrophobic interactions, GEC1 may
have chaperone-like effects for many cell surface proteins
along the biosynthesis pathway.

GEC1-KOPR Interaction

EXPERIMENTAL PROCEDURES
Materials
[15,16-3H]Diprenorphine (⬃56 Ci/mmol) was purchased
from PerkinElmer Life Sciences. Naloxone and rabbit antiFLAG polyclonal antibody were purchased from Sigma. Cell
media (Dulbecco’s modified Eagle’s medium/F-12, 1:1), OptiMEM I reduced serum, fetal bovine serum (FBS), and Lipofectamine transfection reagent were acquired from Invitrogen.
QIAquick gel extraction kit, QIAquick PCR purification kit,
and QIAprep 8 miniprep kit were acquired from Qiagen
(Valencia, CA). Materials for yeast two-hybrid assays such as
bait and prey vectors (pGBKT7 and pGADT7, respectively),
minimal SD agar base, dropout supplement, and Yeastmaker
yeast transformation system 2 kit were purchased from Clontech. The following reagents were purchased from the indicated companies: geneticin (G418) from Cellgro Mediatech
(Herndon, VA); horseradish peroxidase-conjugated goat antirabbit, IgG horseradish peroxidase-conjugated goat antimouse IgG, and Quick Ligation kit from New England Biolabs
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(Beverly, MA); PfuUltra High Fidelity DNA polymerase from
Stratagene (La Jolla, CA); all restriction endonucleases and
dNTP from Promega (Madison WI); and monoclonal antibody
against HA (HA.11) from Covance (Princeton, NJ).
The cDNA construct of the wild-type rat AMPA receptor
subunit GluR1 in pcDNA3.1 and rabbit anti-GluR1 antibody
were generous gifts from Dr. Richard Huganir (Department of
Neuroscience, The Johns Hopkins University, Baltimore). The
cDNA constructs of HA-tagged human prostaglandin receptor
EP3.f and EP3.I in pcDNA3.1 were provided by Dr. Barrie
Ashby (Department of Pharmacology, Temple University, Philadelphia). Rabbit anti-GEC1 polyclonal antibody (PA629p) was
generated previously (10). The following software products
were used: Prism 3.0 program from GraphPad Software Inc.
(San Diego, CA), ImageJ 1.34S from National Institutes of
Health (Bethesda), and OptiQuant (PerkinElmer Life Sciences).
Cell Lines
A clonal CHO cell line stably expressing the FLAG-hKOPR
was generated previously (25), and the Bmax value of FLAGhKOPR was ⬃1.9 pmol/mg protein (26). CHO cells with stable
expression of FLAG-hKOPR-F346A (residue Phe346
replaced by Ala), FLAG-hKOPR-P347A, FLAG-hKOPRM350A, rGluR1, HA-hEP3.f, and HA-hEP3.I were established similarly. For cells stably expressing hKOPR mutants,
further screening using [3H]diprenorphine binding assay
was performed to obtain cells with similar Bmax values as that
of FLAG-hKOPR. All cells were cultured in 10-cm culture
dishes in Dulbecco’s modified Eagle’s medium/F-12 medium
supplemented with 10% FBS, 0.2 mg/ml geneticin in a
humidified atmosphere consisting of 5% CO2 and 95% air at
37 °C.
Transient Expression of GEC1
Lipofectamine-mediated DNA transfection experiments
were performed by following the manufacturer’s protocol with
some modifications. GEC1-pcDNA3.1/Hygro(⫹) was previously constructed (10). Twenty four hours before transfection,
1.8 –2.0 million cells stably expressing FLAG-hKOPR were
seeded on each 10-cm Petri dish. On the experiment day, transfection was carried out with 40 l of Lipofectamine (1 mg/ml),
10 g of the DNA construct or the plasmid vector (control), and
6 ml of Opti-MEM medium per 10-cm dish. At 16 h after transfection, medium was replaced by 10 ml of Opti-MEM containing 10% FBS. Forty hours following transfection, the cells were
harvested for further experiments.
Co-immunoprecipitation of hKOPR and GEC1-(38 –117)
The cDNA construct of wild-type or mutant FLAG-hKOPR
or the vector pcDNA3.1 was co-transfected with HA-GEC1(38 –117) at a ratio of 5:5 (g) into one 100-mm dish of CHO
cells. Forty hours after transfection, two dishes of cells (2 ⫻ 107)
were collected and solubilized in 1 ml of TTSEC (0.5% Triton
X-100, 50 mM Tris, pH 7.5, 0.15 M NaCl, 1 mM EDTA, and
protease inhibitor mixture from Roche Applied Science) for 1 h
at 4 °C. Cell lysates were cleared by centrifugation at 105 ⫻ g
followed by filtration through a 0.2-m filter. One ml of supernatant was incubated with 20 l of anti-FLAG-agarose beads
VOLUME 284 • NUMBER 3 • JANUARY 16, 2009
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A growing body of evidence shows that this protein family is
closely related to two distinct biological functions. Studies
mainly on GABARAP, GATE16, and GEC1 indicate that they
promote intracellular protein trafficking by enhancing vesicle
fusion (10, 16 –21). In addition, they facilitate degradation of
proteins and intracellular organelles via autophagy-related
pathways, which is bolstered largely by research on Atg8 and
LC3 (22, 23).
We previously reported that GEC1 interacted with the
hKOPR C-tail and enhanced cell surface levels of hKOPR stably
expressed in CHO cells. GEC1 expression enhances hKOPR
expression through facilitating its anterograde trafficking along
the protein biosynthesis pathway without affecting degradation
of the receptor (10). This represented the first biological function reported for GEC1. Mansuy et al. (24) demonstrated that
GEC1 interacted with tubulin and promoted microtubule bundling in vitro, and that green fluorescence protein-tagged GEC1
was localized in the perinuclear vesicles with a scattered pattern. Our electron microscopic studies in the rat brain showed
that GEC1 was associated with ER, Golgi apparatus, endosomelike vesicles, and plasma membranes and scattered in cytoplasm in neurons (14). In addition, N-ethylmaleimide-sensitive
factor, a protein critical for intracellular membrane-trafficking
events, binds directly to GEC1 (10).
In this study, we employed Y2H techniques to determine the
amino acid residues in both GEC1 and hKOPR C-tail involved
in the interaction. Further studies were then carried out in
mammalian cells to examine if elimination of the interaction
affected the effect of GEC1 on hKOPR expression. In addition,
we generated a molecular model of GEC1 based on the x-ray
crystal structure of GABARAP and found that the residues
involved in hKOPR binding formed hydrophobic patches on
the exterior surface of GEC1. Moreover, we found that the cytosolic tail of AMPA receptor subunit GluR1 has the same
FPXXM motif as that found in the hKOPR C-tail to be involved
in GEC1 binding and that GEC1 expression up-regulated
GluR1.

GEC1-KOPR Interaction
(M2, Sigma) overnight at 4 °C. The beads were then washed
three times with TTSEC containing 1% Triton X-100 and
extracted in 40 l of loading buffer (4% SDS, 50 mM Tris, pH
6.25, and 100 mM dithiothreitol). Samples were separated on
12% SDS-PAGE and transferred to Immobilon (Millipore), and
immunoblotting of HA-GEC1-(38 –117) and FLAG-hKOPR
was performed with rabbit anti-HA antibody and rabbit antiFLAG antibody, respectively, and followed by enhanced chemiluminescence. Transfection and co-immunoprecipitation of
HA-GEC1-(38 –117) or its mutants with FLAG-hKOPR were
performed similarly. The program OptiQuant (PerkinElmer
Life Sciences) was used to analyze the immunoblotting
results.
[3H]Diprenorphine Binding to hKOPR in Intact Cells

SDS-PAGE and Immunoblotting
Cells were harvested using Versene buffer, solubilized in 2⫻
Laemmli sample buffer, and subjected to Tricine-SDS-PAGE
on 8% separating gel as described previously (10). The separated protein bands were transferred to Immobilon-P polyvinylidene difluoride transfer membranes on which immunoblotting was carried out with primary antibodies, horseradish
peroxidase-linked secondary antibody, and SuperSignal West
Pico Chemiluminescent reagents (10). Primary antibodies used
were rabbit polyclonal anti-FLAG (F7425) antibody (0.8 mg/ml,
1:5000), rabbit polyclonal anti-GluR1 antibody (1:5000) or
mouse monoclonal anti-HA antibody (1 mg/ml, 1:5000). The
protein bands were visualized and then digitalized with Fuji
LAS-1000 Plus gel documentation system (Fuji Film, Tokyo,
Japan). Expression level of transfected GEC1 protein was evaluated by immunoblotting as described above except using 15%
Tricine/SDS-PAGE, boiled (100 °C, 5 min) sample solution,
and rabbit polyclonal anti-GEC1 (PA629p) antibody (0.49
g/ml, 1:7500).
Y2H Assays
The general strategies were to use different hKOPR-C tail
(334 –380) or GEC1-(38 –117) mutants to narrow down (truncation mutants) and then to define (double and single alanine
substitution mutants) the amino acid residues that account for
GEC1-hKOPR interaction. GEC1-(38 –117) is a truncated
GEC1, which was the form originally identified to bind the
hKOPR C-tail in our previous Y2H studies (10).
For determining the amino acid residues in GEC1 involved in
hKOPR binding, GAL4 yeast two-hybrid system was employed
to evaluate interaction between GEC1 mutants and hKOPRJANUARY 16, 2009 • VOLUME 284 • NUMBER 3
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Saturation binding was performed with six concentrations of
[3H]diprenorphine (0.1, 0.2, 0.4, 0.6, 1.0, and 2.0 nM) and
150,000 cells/tube in duplicate in 1 ml of PBS buffer containing
1 mg/ml bovine serum albumin at room temperature for 60
min. Ten M naloxone was used to define nonspecific binding.
The Kell program (known as EBDA previously) was used to
analyze data and to obtain the Bmax and Kd values. Binding with
⬃1 nM [3H]diprenorphine was performed with 200,000 cells/
tube in a similar manner. Naloxone (10 M) was employed to
define the nonspecific binding for total receptors as described
previously (10).

(334 –380). GEC1 mutant cDNA was generated using PCR and
inserted into the prey vector pGADT7 containing a LEU2 selection marker for yeast, which was then transformed into yeast
strain Y187 that is auxotrophic for adenine (Ade), tryptophan
(Trp), histidine (His), and leucine (Leu). Human KOPR-(334 –
380) cDNA was inserted into the bait vector pGBKT7 containing a TRP1 nutritional marker for yeast selection that was then
transformed into yeast strain AH109 that is also auxotrophic
for Ade, Trp, His, and Leu. After selecting transformants on
SD/⫺Leu and SD/⫺Trp media, respectively, the two positive
haploids were mated, and growth status of the diploids on
media with different stringency was monitored and evaluated.
The amino acids in hKOPR C-tail involved in GEC1 binding
were determined with the same method except that the plasmid
constructs of hKOPR-(334 –380) mutants/pGBKT7 and
GEC1-(38 –117)/pGADT7 were used.
Plasmid Construction for Y2H—N and C termini of GEC1(38 –117) were truncated by an increment of 10 and 2 residues
via a series of PCRs. The PCR products digested with restriction
enzymes EcoRI and BamHI were ligated into the prey vector
pGADT7. After delineating the hKOPR binding region using
aforementioned GEC1-(38 –117) truncation mutants, single
alanine substitution mutants were generated within the 40 – 67
and 109 –113 fragments of GEC1-(38 –117) by overlap PCR to
define the residues required for the GEC1-hKOPR interaction.
With the same strategy, five-amino acid truncation, double and
single alanine substitution mutants of hKOPR-(334 –380) in
pGBKT7 (NdeI/SalI) were established. All the resulting DNA
plasmids were purified using QIAprep Spin Miniprep kit. DNA
sequences of the inserts were verified by the University of Pennsylvania DNA sequencing facility.
Transformation of Yeast Cells—Transformation of yeast with
constructs was carried out using standard PEG/LiAc protocol
as described in our previous publication (10).
Mating of Yeast Cells—The two mating partner strains, Y187
and AH109, were transformed with prey (GEC1/pGADT7) and
bait (hKOPR-C/pGBKT7) plasmids, respectively. Transformants were selected using the proper SD dropout medium, and
the mating was conducted in 96 six-well plates. For both transformants, a single colony (2–3 mm, less than 1 month old) was
suspended in 1 ml of 2⫻ YPDA/kanamycin medium. Twenty l
each of the Y187 and the AH109 cell suspension was added to
one well containing 200 l of 2⫻ YPDA medium with kanamycin (10 g/ml) and mixed well. The plate was then incubated at
30 °C for 16 –18 h on an orbital shaker set at 200 rpm. Mating
reactions were monitored for diploid formation using phasecontrast microscope (27). The mating culture was diluted with
physiological saline and then plated in a volume of 100 l onto
SD medium with three levels of stringency: double dropout
(2DO) SD/⫺Leu/⫺Trp, triple dropout (TDO) SD/⫺Leu/
⫺Trp/⫺His, and quadruple dropout (QDO) SD/⫺Leu/⫺Trp/
⫺His/⫺Ade. The plates were incubated upside-down at 30 °C
for 5–7 days to obtain well separated colonies with a diameter
of 1–3 mm. Dilution factor for the mating culture was adjusted
so that the resulting colony number of the diploid on the 2DO
plate was 200 – 400.
Assessment of the Protein-Protein Interaction—Throughout
the yeast two-hybrid assays, the mating mixture of GEC1-(38 –

GEC1-KOPR Interaction
117)/pGADT7 and hKOPR-C(334 –380)/pGBKT7 was used as
the positive control and GEC1-(38 –117)/pGADT7 combined
with pGBKT7(⫺) as the negative control. Plasmid pGBKT7(⫺)
was derived from the pGBKT7 vector of which the sequence
between the NdeI site and SalI site (in the multiple cloning
sites) was deleted. Five to 7 days after yeast mating, the colony
number on the SD agar plates was counted using software
ImageJ 1.34S. For each mating reaction, the diploid number on
TDO and QDO plates was normalized against that on 2DO
plate. Then the normalized numbers were compared with its
counterparts in the positive control group. The protein-protein
interaction between GEC1-(38 –117) and hKOPR C-tail was
considered to be strong (⫹⫹⫹), moderate (⫹⫹), weak (⫹), or
absent (⫺) if the resulting percentages were larger than 80%,

between 30 and 80%, between 5 and 30%, or less than 5%,
respectively.
Structural Modeling of GEC1
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Initial Model—Although no crystal structure of GEC1 has
been published, GEC1 shares 86% identity with GABARAP. So
the 1.75-Å resolution GABARAP x-ray crystal structure (Protein Data Bank code 1GNU) (28) served as template here for an
initial (united atom) GEC1 model. The GABARAP/GEC1
sequence alignment presented in Chen et al. (10) (also see Fig.
9A) was used as input to Modeler (version 9.1) (29, 30). The
GEC1 model with the lowest objective function out of 100
models generated was chosen for further refinement. Hydrogens were added to the model using Maestro version 8.0.110
(Schrödinger, LLC, New York), with a short minimization
performed to optimize the hydrogen positions. Energy minimization was performed using Macromodel version 9.5 (31)
TABLE 1
and the OPLS2005 all atom force field. A distance-dependEffect of GEC1 expression on 关3H兴diprenorphine binding to the KOPR
stably transfected into CHO cells
ent dielectric, 8.0-Å extended nonbonded cutoff, 20.0-Å
Cells were transiently transfected with GEC1 or the vector pcDNA3.1. Forty hours
electrostatic cutoff, and 4.0-Å hydrogen bond cutoff were
3
later, saturation binding of 关 H兴diprenorphine (six concentrations ranging from 0.1
used. The minimization consisted of 500 steps (Polak-Ribier
to 2 nM, including 1 nM) to the receptor was performed, and Kd and Bmax values were
calculated. The percent change in KORP expression level measured by 1 nM
conjugate gradient method) with backbone and side chain
3
关 H兴diprenorphine binding was determined, which is consistent with that in Bmax
heavy atoms fixed.
value. 关3H兴Diprenorphine (1 nM) binding was therefore chosen to measure the
changes of receptor expression in all subsequent experiments. Data are expressed as
Molecular Dynamics of Apo-GEC1 in an Aqueous Environmeans ⫾ S.E. (n ⫽ 3). ** indicates p ⬍ 0.01 compared with the control group by
ment—NAMD2
(32) molecular dynamics simulations were
Student’s t test.
used
to
relax
the
initial GEC1 model in an aqueous environ% increase of control
Cells
Bmax
transfected
Kd
fmol/106
ment.
10
Å
of
waters
in each direction of the protein were
1 nM
Bmax
with
cells
关3H兴diprenorphine
added using the VMD Solvate package, and the VMD MeadinM
onize plugin was employed to achieve electroneutrality.
Control vector 0.13 ⫾ 0.01 70.00 ⫾ 0.67
NAMD2 calculations used the CHARMM27 parameter set
GEC1
0.17 ⫾ 0.02 129.90 ⫾ 0.83** 85.6 ⫾ 2.3
84.4 ⫾ 3.1
(33–35) and the TIP3P model for water. Periodic boundary
conditions were employed with
the long range coulombic electrostatic potential treated with the
Particle-Mesh Ewald summation
method (36). The Lenard-Jones
potential was smoothly cut off
between 8.5 and 10 Å. The
NAMD2 simulation used the
r-RESPA multiple time step algorithm with a time step of 4 fs for
long range electrostatic forces, 2 fs
for short range nonbonded forces,
and 1 fs otherwise. The simulation
cell was minimized for 20 ps (5 ps
with heavy atoms fixed and 15 ps
with all atoms unrestrained).
Using Langevin coupling to a heat
FIGURE 1. Mapping the GEC1-binding motif in the C-tail of hKOPR using Y2H assays. A, summary of Y2H bath, the cell was warmed to 310 K
results. Truncation and double and single alanine substitution mutants of hKOPR C-tail were examined for their (NVT ensemble) in 10° increments
abilities to interact with GEC1-(38 –117). The hKOPR C-tail mutants were generated by PCR, constructed into for 20 ps with the backbone conGAL4-binding domain vector pGBKT7, and transformed into yeast strain AH109. The GEC1-(38 –117) was con2
structed into GAL4 activation domain vector pGADT7 and transformed into yeast strain Y187. The two trans- strained using a 0.5 kcal/mol Å
formed yeast strains mated, and the mating mixtures were cultured on SD/⫺Trp/⫺Leu (2DO), SD/⫺Trp/⫺Leu/ harmonic force. 1.25 ns of equili⫺His (TDO), and SD/⫺Trp/⫺Leu/⫺His/⫺Ade (QDO) agar plates. The resulting diploid colonies were counted,
bration (NPT; 310 K/1 atm) was
and the ratio of the number of colony-forming units on TDO/QDO plates over colony-forming units on the 2DO
plate was used to evaluate the interaction strength of each pair of GEC1-(38 –117) and hKOPR C-tail mutant. performed in 0.25-ns runs with a
Assessment details were described under “Experimental Procedures.” The experiments were performed three decreasing backbone harmonic
times with reproducible results. Results on truncation and double alanine substitution mutants are shown in
supplemental Fig. 1. B, amino acid sequence alignment of C-tails of the human opioid receptors demonstrating constraint for each run (0.5, 0.25,
that the defined GEC1 binding region is hKOPR-specific.
0.10, 0.05, and 0.0 kcal/mol Å2).

GEC1-KOPR Interaction
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% Increase of [ H]diprenorphine binding
(total receptors)

Ratio of GEC1/Receptor
(%, arbitrary units)

formed per temperature with a run
consisting of 50,000 steps applied
120
to all peptide torsion and bond
100
angles, allowing them to vary
⫾180 and ⫾8°, respectively. The
80
CM
biased-annealing
phase,
*
60
began at T ⫽ 749.4 K, cooling to
310 K in nine steps. The peptide
40
*
was drawn to the GEC1 surface
using a planar restraint on the
20
**
peptide center of mass (k ⫽ 0.025
0
kcal/mol Å2), and the center of
Wt
F346A
P347A
M350A
mass was confined spatially using
a cylindrical restraint (k ⫽ 0.02
107
120
kcal/mol Å2; 15.7 Å diameter cir98
cle at the protein surface, T ⫽ 310
100
K). To account for electrostatic
screening in water, a distance-de80
pendent, nonlinear (sigmoidal)
screened Coulomb potential as
60
described by Hassan et al. (40, 41)
(average screening parameter
40
***
1.0367) was employed, with the
21.8
dielectric constant decreased from
20
***
***
1.8
80 to 1, based on the distance
2
between the peptide center of
0
mass and the protein surface.
FIGURE 2. A, F346A, P347A, and M350A mutations in the hKOPR C-tail reduced co-immunoprecipitation of
The 102 octapeptide-GEC1
GEC1-(38 –117). GEC1-(38 –117) was co-transfected into CHO cells with wild-type (wt) or a mutant FLAG-hKOPR
complexes
(holo-GEC1) output at
or the control vector. The receptors were immunoprecipitated (IP) with anti-FLAG (M2)-agarose beads 40 h
after transfection. The SDS-PAGE was performed, and the GEC1-(38 –117) (GEC1 co-IPed, 1st row) and hKOPR 310 K were screened using the cri(receptor IPed, 2nd row) were detected with immunoblotting (IB) with anti-HA antibody and anti-FLAG anti- teria that the GEC1-binding motif
bodies, respectively. The ratios of density of GEC1-(38 –117) over receptor were normalized against that of
wild-type receptor and are shown in the graph at right. Each value represents the mean ⫾ S.E. of three inde- (FPXXM) of the hKOPR C-termipendent experiments. *, p ⬍ 0.05, and **, p ⬍ 0.01 compared with wild-type group using one-way ANOVA nal peptide (residues Phe2, Pro3,
followed by Tukey’s post hoc test. B, effects of GEC1 on expression of the wild-type and alanine-substituted
and Met6) is critical for GEC1
mutants (F346A, P347A, M350A, and R351A) of FLAG-hKOPR. Wild-type hKOPR and its alanine-substituted
mutants were cloned in pcDNA3.1 and then stably expressed in CHO cells. Wild-type and mutated receptors interaction and that the first
were expressed at similar levels (⬃1.9 pmol/mg protein). GEC1 or the vector pcDNA3.1 (control) was transiently octapeptide residue (Cys1), being a
transfected into these cells. [3H]Diprenorphine (1 nM) binding to hKOPR was performed on intact cells 40 h after
transfection. Data were expressed as the percentage of increase in [3H]diprenorphine binding in GEC1-trans- putative palmitoylation site, needs
fected cells compared with the control cells. Each value represents the mean ⫾ S.E. of three independent to be unobstructed. The complex
experiments. ***, p ⬍ 0.005 compared with wild-type group using one-way ANOVA followed by Tukey’s post that best met these criteria was
hoc test.
then equilibrated in water via
NAMD2 MD simulations.
Molecular Dynamics of Holo-GEC1
in Aqueous Environment—The
Once the protein was equilibrated, a 10-ns production run NAMD2 settings used for apo-GEC1 detailed above were
used to equilibrate holo-GEC1 in water, with the exception
was initiated (NPT; 310 K/1 atm).
Conformational Memories—The Monte Carlo/simulated that the water box extended 12 Å from the complex surface
annealing method, Conformational Memories (CM) (37– in all directions. After minimization (heavy atoms fixed), the
39), was used to explore (in the presence of GEC1) the low simulation cell was warmed to 310 K in 10° increments for 20
free energy conformations of an octapeptide from the C ter- ps (heavy atoms fixed), and then run for 1 ns with harmonic
minus of the hKOPR that contains the GEC1-binding motif, constraints to maintain the complex while the system was
FPXXM (CFPLKMRM). The GEC1 model, taken from the solvated. Because the equilibrated apo-GEC1 was used for
MD trajectory, was that frame in which key KOPR C-termi- the complex, a heavy atom harmonic constraint of 1.0 kcal/
nal interaction residues were most exposed. The CHARMM mol Å2 was employed for GEC-1, whereas a 0.5 kcal/mol Å2
force field was employed for this calculation. In the CM harmonic constraint was placed on the following: (i) the pepexploratory phase, the peptide was positioned 59 Å above tide Phe2, Pro3, and Met6 C-␣ atoms; (ii) the most extreme
GEC1 at T ⫽ 3000 K. Then the peptide was drawn toward the Phe2 and Pro3 carbons; and (iii) the Met6 sulfur and its adjaGEC1 surface in 18 steps (3.28 Å/step) as the temperature cent methylene carbon to maintain the CM identified comwas decreased to T ⫽ 310 K (18 steps). 102 runs were per- plex. The system was minimized (NVT), and then a 1.5-ns

GEC1-KOPR Interaction
equilibration was followed by a 5-ns production run (NPT;
310 K/1 atm) using the same constraints as the warm up and
equilibration.

ance (ANOVA) followed by a Tukey post hoc test. If the p value
less than 0.05, the difference was defined as significant. All statistical analyses were performed using GraphPad Prism 3.0.

Data Analysis
All quantitative data were present as mean ⫾ S.E. if they were
derived from at least 3⫻ experiments. For comparison of multiple groups, the data were analyzed by one-way analysis of vari-

RESULTS
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Effect of GEC1 on KOPR Expression—Results of saturation
binding of [3H]diprenorphine, an antagonist, revealed that
GEC1 expression resulted in 85% increase in Bmax value
compared with the control, but there was no change in the
Kd value (Table 1). When binding was conducted with ⬃1 nM
[3H]diprenorphine, a concentration close to saturation,
the percentage increase in KOPR binding was ⬃84%. We
therefore performed binding with 1 nM [3H]diprenorphine,
rather than saturation binding, in the subsequent
experiments.
Determination of GEC1-binding Sequence in the hKOPR
C-tail—Two series of truncation mutants were generated by
deleting five amino acids incrementally from the N terminus
and the C terminus, respectively, and their interactions with
344
FCFPLKFIGURE 3. Permutations of the GEC1-binding motif in the hKOPR C-tail. GEC1-(38 –117) were examined. The fragment
Phe346, Pro347, and Met350 in the hKOPR C-tail were replaced, one at a time, MRMERQSTSRV360 appeared to be necessary for the interwith the indicated amino acids. The interactions of the hKOPR C-tail mutants action (supplemental Fig. I). We then generated double alawith GEC1-(38 –117) were evaluated in Y2H assays as described in Fig. 1. The
nine substitution mutants of the hKOPR C-tail within this
experiments were performed three times with similar results.
fragment, and their interactions
with GEC1-(38 –117) were examined. We found that the residues
346
FP347 and 350MR351 were essential (supplemental Fig. I). Single
alanine substitution mutations
were subsequently carried out,
and Phe346, Pro347, and Met350
were found to be critical (Fig. 1A).
In addition, Phe344, Cys345, Leu348,
and Lys349 appeared to be involved
in the GEC1-hKOPR interaction,
but they were not as important
(Fig. 1A). Thus, the GEC1-binding
sequence was defined as FPXXM.
Sequence alignment (Fig. 1B) of
the C-tails of human opioid receptors (, ␦, and ) revealed that this
sequence was unique to the KOPR
among the opioid receptors.
We then investigated if mutations in the FPXXM sequence in
the hKOPR C-tail affected interaction of the hKOPR with GEC1 in
CHO cells. Three single alanine
substitution FLAG-hKOPR mutants, F346A, P347A, and M350A,
were constructed, and CHO cells
stably expressing each mutant
FIGURE 4. Mapping of the residues in GEC1 involved in binding to hKOPR using Y2H assays. Serial trun- were established. We have prevication and substitution mutants of GEC1-(38 –117) were examined for their ability to interact with hKOPR C-tail.
ously demonstrated that although
GEC1-(38 –117) mutants were generated by PCR, constructed into GAL4 activation domain vector pGADT7,
and transformed into yeast strain Y187. The hKOPR C-tail was constructed into GAL4-binding domain vector GEC1 immunoprecipitated with
pGBKT7 and transformed into yeast strain AH109. The two transformed yeast strains mated, and the mating hKOPR, the signals appeared to be
mixtures were selected, and interaction strength was evaluated as described in Fig. 1. The experiments were
performed three times with reproducible results. Results on truncation and double alanine substitution weak (10), most likely because of
mutants are shown in supplemental Fig. II.
the strong interaction of GEC1
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%Increase of [ 3H]diprenorphine binding
(total receptors)

Ratio of GEC1/Receptor
(%, arbitrary units)

hKOPR C-tail did not affect its
interaction with GEC1 (see above).
120
Thus, the data from Y2H assays,
co-IP, and functional studies indi100
cate that Phe346, Pro347, and Met350
80
are critical for the interaction
between GEC1 and hKOPR, which
*
60
results in up-regulation of the
*
40
hKOPR.
Permutations of the FPXXM
20
Sequence—We further characterized structural requirements of the
0
GEC1(38-117) V57A
F60A
GEC1-binding motif. We generated
the following single mutants in the
100.0
hKOPR C-tail: mutations of Phe346
to Tyr, Trp, His, and Leu; Pro347 to
Gly; and Met350 to Cys, Ser, Thr,
80.0
70.8
63.8
Asp, Asn, Leu, and Lys. We found
62.1
that, at the position 346, having Tyr
52.0
*
60.0
48.9
and Trp substitutions resulted in
*
42.6
robust interaction with GEC1, but
His or Leu did not (Fig. 3), indicat40.0
**
28.4
ing that the aromatic ring is indis**
22.6
pensable. For the 347 position, sub20.0
stitution of Pro with the simplest
and most flexible residue glycine
totally abolished the binding, dem0.0
onstrating that that the kink strucFIGURE 5. A, V57A or F60A mutation in GEC1-(38 –117) GEC1 reduced its co-immunoprecipitation with FLAG- ture is critical for the two proteins to
hKOPR. Wild-type GEC1-(38 –117) or its mutant was co-transfected into CHO cells with wild-type FLAG-hKOPR bind. Change of Met350 to acidic,
or the control vector. The receptors were immunoprecipitated (IP) using anti-FLAG (M2)-agarose beads 40 h
after transfection. SDS-PAGE was performed, and GEC1-(38 –117) and the mutants (GEC1 co-IPed, 1st row) and basic, or polar residue eliminated
FLAG-hKOPR (receptor IPed, 2nd row) were detected with immunoblotting (IB). The ratios of density of GEC1- GEC1-hKOPR
interaction, but
(38 –117) or the mutants over FLAG-hKOPR were normalized against that of wild-type GEC1-(38 –117) and are
substitution
with
the hydrophobic
shown in the graph at right. Each value represents the mean ⫾ S.E. of three independent experiments. *, p ⬍
0.05 compared with wild-type group using one-way ANOVA followed by Tukey’s post hoc test. B, effects of residue Leu had little effect on the
single alanine substitution of the critical residues in the hKOPR-binding motif on the GEC1-induced enhance- interaction. Therefore, lipophilic
ment in FLAG-hKOPR expression. Wild-type GEC1 and its alanine-substituted mutants were cloned in
pcDNA3.1 and then transiently transfected into CHO cells stably expressing FLAG-hKOPR. Forty hours after residue at the 350 position is importransfection, [3H]diprenorphine (1 nM) binding to hKOPR was performed on intact cells. Data were expressed as tant for GEC1 binding. Therefore,
the percentage of increase in [3H]diprenorphine binding in GEC1-transfected cells compared with the control the
GEC1-interacting FRXXM
cells that were transfected with the vector pcDNA3.1. Each value represents the mean ⫾ S.E. of five independent experiments. *, p ⬍ 0.05, and **, p ⬍ 0.01 compared with wild-type group using one-way ANOVA followed sequence can be expanded to (Phe,
by Tukey’s post hoc test.
Tyr, Trp(Pro-XX)Met, Leu), which
is a kink-producing hydrophobic
with microtubules via its N-terminal region. The tubulin- fragment. As Leu and Ile are very similar, it is possible that
binding domain of GEC1 was mapped to the fragment Met350 can be replaced with Ile.
(amino acids 1–22) (24). We found that the amount of
Determination of hKOPR-binding Domain in GEC1-(38 –
GEC1-(38 –117) immunoprecipitated with the hKOPR was 117)—GEC1-(38 –117) was employed as the starting construct
higher than that of GEC1 (data not shown); therefore, GEC1- because it was found to interact with the hKOPR-C tail in the
(38 –117) was used in the co-immunoprecipitation experi- original Y2H screening (10). With the 10-amino acid truncaments. GEC1-(38 –117) was transiently transfected, and co- tion mutants of GEC1-(38 –117), we found that at least the
immunoprecipitation was examined. As shown in Fig. 2A, (38KARVPDLDKRKYLVPSDLTV57) fragment in the N-termisubstitutions of Phe346, Pro347, or Met350 with Ala signifi- nal region and the (108AYSDESVYGK117) fragment in the
cantly reduced the amount of GEC1-(38 –117) co-immuno- C-terminal region were required for the interaction (suppleprecipitated with FLAG-hKOPR.
mental Fig. II). Serial double-truncation mutants of GEC1We next determined whether mutations in the FPXXM (38 –117) within these two regions were generated and examsequence in the hKOPR C-tail influenced up-regulation of ined. We found that, at least, the amino acid residues 44LD45,
KOPR by GEC1 in CHO cells. As shown in Fig. 2B, the enhanc- 50LVPS53, and 108AYSD111 were required for GEC1 to interact
ing effect of GEC1 on hKOPR expression was greatly reduced with the hKOPR (supplemental Fig. II).
by F346A, P347A, and M350A mutations (p ⬍ 0.005) but not by
Alanine substitution scanning studies in the fragments
R351A mutation. In Y2H assay, R351A substitution in the 40RVPDLDKRKYLVPSDLTVGQFYFLIRKR67 and 109YSDES113
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GluR1 C-tail:
EFCYKSRSESKRMKGFCLIPQQSINEAIRTSTLPRNSGAGASGGGGSGENGRVVSQD FPK
SMQSIPCMSHSSGMPLGATGL
3

**
2.29

Fold of control

2.5
2

*

1.43

1.5
1.07

1
0.5
0

Vector

GEC1

V57A

EP3.I C-tail:
FCQIRYHTNNYASSSTSLPCQCSSTLMWSDHLER

2

Vector
GEC1
V57A

*

Fold of control

1.5

1.5

1

0.99

1.08
1

1

0.5

0
EP3.f

EP3.I

FIGURE 6. Effect of GEC1 on expression of GluR1 and EP3.f, which contain the GEC1-binding motif or a similar sequence. Amino acid sequences of the
cytosolic C-tails of AMPA receptor subunit GluR1 (A), prostaglandin receptor EP3.f, and EP3.I (B) are shown. The matched patterns (FPXXM or FPXM) are
underlined and in boldface. Effects of GEC1 or its V57A mutant on expression of GluR1 (A) and HA-EP3.f and HA-EP3.I prostaglandin (B) receptors stably
expressed in CHO cells were examined. Cells were transiently transfected with GEC1 or its V57A mutant. Forty hours after the transfection, immunoblottings
were performed in duplicate with 200,000 cells in Laemmli sample buffer (per lane). GluR1, GEC1 and prostaglandin receptors were detected with rabbit
anti-GluR1, rabbit anti-GEC1, and mouse monoclonal anti-HA antibodies, respectively. Each value represents the mean ⫾ S.E. of three independent experiments. *, p ⬍ 0.05, and **, p ⬍ 0.01 compared with wild-type group using one-way ANOVA followed by Tukey’s post hoc test.

were performed. The Y2H results showed that residues Tyr49,
Val51, Leu55, Thr56, Val57, Phe60, and Ile64 were indispensable
for GEC1-(38 –117) to bind to the hKOPR C-tail (Fig. 4). In
addition, five other residues, Leu44, Leu50, Tyr61, Arg65, and
Tyr109, appeared to be involved (Fig. 4).
We then investigated if single alanine-substituted full-length
GEC1 mutants interacted with the hKOPR in CHO cells, using
V57A and F60A as the representatives. As shown in Fig. 5A,
alanine substitution of Val57 or Phe60 in GEC1 greatly reduced
its interaction with hKOPR. Subsequently, we examined if alanine substitution at Tyr49, Val51, Leu55, Thr56, Val57, Phe60, or
Ile64 affected the effect of GEC1 on hKOPR expression. Transient expression of each of the seven mutants resulted in less
up-regulation of hKOPR than the wild-type GEC1, and the
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decreases caused by alanine substitution mutation at Leu55,
Thr56, Val57, and Phe60 were statistically significant (Fig. 5B).
Other Receptors Containing FPXXM or a Similar Sequence—
A search of the Swiss Protein Database revealed that many proteins contain FPXXM sequence. The C-tail of AMPA receptor
subunit GluR1 contains such a sequence (Fig. 6A). Using CHO
cells stably transfected with GluR1, we found that transient
expression of the wild-type GEC1, but not V57A GEC1,
enhanced GluR1 expression (Fig. 6A).
Prostaglandin receptor EP3.f has a FPXM sequence in its
C-terminal domain (Fig. 6B), which is similar, but not identical, to FPXXM. In CHO cells stably transfected with EP3.f,
expression of wild-type GEC1, but not the V57A mutant,
enhanced the level of the EP3.f receptor (Fig. 6B). In conVOLUME 284 • NUMBER 3 • JANUARY 16, 2009
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B.
EP3.f C-tail:
FCQMRKRRLREQAPLLPTPTVIDPSRFCAQPFRWFLDLSFPAMSSSHPQLPLTLASFKLL
REPCSVQLS
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Among the 100 models produced by
Modeler, the one with the lowest
objective function was chosen for
further refinement (see Fig. 7A).
The GEC1 model is composed of
an N-terminal helical region (residues 1–25) that is highly basic and a
core structure (residues 27–117)
with a typical ␤-grasp ubiquitin-like
folding. The basic N-terminal
domain of GEC1 consisting of two
␣-helices (1 and 2) has been suggested to be responsible for mediating direct interaction with microtubules. Following residue Pro26, the
core domain of GEC1 structure
includes four ␤-strands (strands
1– 4) and two ␣-helices (helices 3
and 4), the two middle strands
(strands 1 and 4) parallel to each
other, and the two outer strands
(strands 2 and 4) anti-parallel to
their neighboring inner strands,
respectively. ␣-Helix 3 is located
between ␤-strands 2 and 3, whereas
␣-helix 4 is between ␤-strands 3 and
4. Fig. 7B shows spatial orientations
of residues of primary importance
for GEC1 interaction with the
hKOPR C terminus in magenta and
those of secondary importance in
cyan.
Molecular Dynamics of ApoGEC1 in an Aqueous Environment;
KOPR C-tail Binds to Hydrophobic
Patches on the Surface of GEC1—
The 10-ns production run trajectory of GEC1 in an aqueous environment was analyzed to identify a
GEC1 conformation that most
FIGURE 7. Molecular model of GEC1. A, molecular model of GEC1 created by using the structure of GABARAP exposed key residues identified to
as the template. B, view of residues that are critical for (magenta color) and involved in (cyan) interaction with be critical for binding. We found
the hKOPR C-tail as determined by the Y2H assays. Spatial orientations of side chains (in stick format in magenta
63
1 torsion
and cyan) of these residues are displayed. C and D, GEC1 model derived from the NAMD2 trajectory. The model that when the Leu
represents that frame from the trajectory in which key residues were most exposed. D, model in C has been angle was in g⫹ (⫺60°), the binding
rotated by 90° about the x axis. C and D, color schemes of residues are identical to B; residues of primary
site was more exposed than when
importance are shown in magenta (Tyr49, Val51, Leu55, Thr56, Val57 (not visible in either view), Phe60, Ile64), and
residues of secondary importance are shown in cyan (Leu44, Leu50, Tyr61, Arg65, and Tyr109 (not visible in either this torsion was trans (⫺180°). In
view)). E, intramolecular interaction between Leu44 and Tyr109. This image results from a 90° clockwise rotation addition, GEC1 clearly underwent
about the vertical y axis from the view in B. Side chains of these two residues may interact through van der
a “breathing” motion during the
Waals forces, which may contribute to structural stability of GEC1.
simulation, permitting the identitrast, GEC1 had no impact on expression of the EP3.I, a fication of a conformation that most exposed key residues.
splice variant of the EP3.f that does not have the FPXM This conformer is illustrated in Fig. 7, C and D, which show
sequence (Fig. 6B). Thus, it is very likely that GEC1 directly two views of the GEC1 surface. Residues found to be of priinteracted with GluR1 and EP3.f through similar sequences mary importance for GEC1 interaction with the KOPR C-tail
are colored magenta in Fig. 7, C and D, (Tyr49, Val51, Leu55,
in the receptor C-tails.
Molecular Model of GEC1—The x-ray crystal structure of Thr56, Val57 (not visible in the views), Phe60 and Ile64),
GABARAP (28) (Protein Data Bank code 1GNU) was employed whereas residues found to be of secondary importance
as a template for the GEC1 model given the high sequence (Leu44, Leu50, Tyr61, Arg65, and Tyr109 (not visible in the
similarity (94%) and identity (86%) of GEC1 with GABARAP. views)) are colored cyan.
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FIGURE 8. A and B, molecular dynamics output of the hKOPR C-terminal
octapeptide-GEC1 complex identified by Conformational Memories. The
octapeptide containing the FPXXM GEC1-binding motif is shown on the
surface of GEC1 in tube display with F2 in orange, P3 in green, and M6 in
yellow. B, those same amino acids are displayed contoured at their van der
Waals radii.

DISCUSSION
Hydrophobic Interactions Mediate GEC1-hKOPR Binding—
We found that seven residues, Tyr49, Val51, Leu55, Thr56, Val57,
Phe60, and Ile64, spanning from ␤-strand 2 to ␣-helix 3, were
indispensable for GEC1 to bind to the hKOPR, whereas five
other residues, Leu44, Leu50, Tyr61, Arg65, and Tyr109, were
involved in the interaction, but to lesser extent. GABARAPbased model of GEC1 demonstrates a hydrophobic patch on
the surface of GEC1 formed by Tyr49, Val51, Leu55, Thr56,
Phe60, and Ile64 (around the S2 ␤-strand), which is extended by
Leu50 (Fig. 7). Tyr61 and Arg65 formed another small patch.
Because of the lipophilic nature of the GEC1-binding sequence
in hKOPR C-tail, FPXXM, it is very likely that the interaction
resulted from hydrophobic contacts between the two proteins.
Studies on the GABARAP crystal structure also suggest a
hydrophobic surface consisting of the residues Ile21, Pro30,
Tyr49, Leu50, Val51, Leu55, Phe60, Leu63, and Phe104, which is
required for formation of head-to-tail GABARAP oligomer
(42). X-ray crystal structure of GATE-16 showed similar
exposed hydrophobic patches formed by Ile21, Pro30, Tyr49,
Leu50, Val51, Pro52, Ile55, Trp62, Ile63, and Phe104. This is the
largest conserved patch of surface between GATE-16 and yeast
Atg8 and was predicted to be functionally important in proteinprotein interactions (43). Comparison between these three
hydrophobic surfaces shows striking conservation of residue
VOLUME 284 • NUMBER 3 • JANUARY 16, 2009
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Each residue that is critical for interaction has a hydrophobic
side chain or an aromatic ring, except Thr56. As shown in Fig.
7B, all side chains of these amino acids, with the exception of
the isopropyl group of Val57, appeared to orient in similar directions, forming a curved hydrophobic surface (around the S2
␤-strand) (Fig. 7, C and D). In addition, the lipophilic isobutyl
group of Leu50 in ␤-strand 2 appeared to enlarge this hydrophobic surface of GEC1, although its side chain did not point to the
same direction. This curved face in GEC1 likely fits well with
the kinked hydrophobic FPXXM motif in hKOPR C-tail. Moreover, the side chains of Tyr61 and Arg65 in ␣-helix 3 were very
close spatially and appeared to be on the same GEC1 surface
(Fig. 7, B–D).
The Y2H data revealed that Leu44 and Tyr109 of GEC1 were
important for its interaction with the hKOPR C-tail. The model
of GEC1 showed that part of the Leu44 side chain was exposed
to the surface, whereas the entire residue of Tyr109 was in the
interior of the protein (Fig. 7, B–D). Fig. 7E clearly demonstrated that Leu44 and Tyr109 likely have a direct intramolecular
interaction between their hydrophobic side chains, which may
act to maintain the three-dimensional GEC1 conformation that
is essential for interaction.
The molecular dynamics output of the hKOPR C-terminal
octapeptide (CFPLKMRM)-GEC1 complex identified by Conformational Memories is illustrated in Fig. 8. In this complex,
the peptide FPXXM-binding motif residues are illustrated at
the top in tube display (Fig. 8A), and below (Fig. 8B) these residues are contoured at their van der Waals radii, with Phe2
colored orange, Pro3 colored green, and Met6 colored yellow. It
is clear here that the peptide FPXXM-binding motif residues
contact the Tyr49/Val51/Leu55/Thr56/Phe60/Ile64 region of
GEC1 (Fig. 8B, colored magenta). The energy of interaction of
these important amino acids with the GEC1 model was found
to be dominated by van der Waals forces. The interaction energies were ⫺110.25 kcal/mol for Phe2, ⫺68.42 kcal/mol for Pro3,
and ⫺109.48 kcal/mol for Met6.
Effects of GABARAP and GATE16 on Expression of
FLAG-hKOPR—Sequence alignment (Fig. 9A) demonstrated
that all seven critical residues were completely conserved
between GEC1 and GABARAP, and that, except similar residue
at position 55, all the other six amino acids were identical
between GEC1 and GATE16. We examined whether these two
proteins enhanced FLAG-hKOPR expression like GEC1. As
shown in Fig. 9B, both GABARAP and GATE16 greatly
enhanced the expression of FLAG-hKOPR. However, GATE16
up-regulated hKOPR to a significantly lower extent than GEC1.
Tubulin-binding Domain Is Important for GEC1 to Promote
hKOPR Expression—Microtubule is one type of cytoskeletons
that determine organelle positions and control intracellular
transport. GEC1-(38 –117) does not have the first 37 amino
acids and thus lacks the tubulin-binding domain (24). Compared with the full-length GEC1 (Fig. 9), GEC1-(38 –117)
caused a significantly lower extent of hKOPR up-regulation
(p ⬍ 0.01), indicating that binding to tubulin cytoskeleton is
important for the effect of GEC1 on hKOPR expression. However, the possibility cannot be excluded that truncation causes
changes in three-dimensional GEC1 conformation that may
affect GEC1-hKOPR binding.
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ing structural integrity. Thus native
conformations are essential for
GEC1 to bind hKOPR C-tail.
GABARAP and GATE16 Also
Enhanced hKOPR Expression—
GABARAP and GATE16 up-regulated hKOPR but to lower extents
than GEC1. These results indicate
that these three proteins are redundant in their functions, at least to
some extent. This inference is
strongly supported by the finding
that deletion of GABARAP in mice
did not influence expression and
subcellular distribution of the
GABAA receptor (44). GEC1 interacts with the ␥2 subunit of the
GABAA receptor (24) and may have
similar effects on this receptor as
GABARAP.
GATE16 increased hKOPR expression to a significantly lower
extent than GEC1 and GABARAP
(Fig. 9). Because the residues in
GEC1 critical for binding the KOPR
C-tail are highly identical, except
Leu55 in GEC1 and Ile55 in GATE16,
the difference may stem from dissimilarity in their three-dimensional structures. There are differences between GATE-16 and
GABARAP in the putatively flexible
C-terminal residues and smaller differences in helix 2 and loop regions
(28, 42, 43, 45, 46).
Microtubules Are Involved in
GEC1-induced Enhancement in
hKOPR Expression—We have
demonstrated by pulldown techniques that GEC1 interacts
directly with tubulin (10). Mansuy
et al. (24) defined the tubulinbinding motif in GEC1 to be the
FIGURE 9. Effects of GEC1 and its analogues on FLAG-hKOPR expression. A, amino acid sequence alignment
of GEC1, GABARAP, and GATE16 showing the highly conserved nature of the 12 GEC1 residues involved in fragment (amino acids 1–22) in
interaction with hKOPR. B, GEC1 up-regulated FLAG-hKOPR to a higher extent than GABARAP, GATE16, and the N-terminal domain, similar to
GEC1-(38 –117). Ten g of vector, GEC1, GEC1-(38 –117), GABARAP, or GATE16 cDNA was transfected, and the (amino acids 1–27) fragment
receptor binding assays were conducted 40 h later. Results are expressed as mean ⫾ S.E. of three experiments.
*, p ⬍ 0.05, and **, p ⬍ 0.01 compared with GEC1 group using one-way ANOVA followed by Tukey’s post hoc in GABARAP (42). The x-ray crystest. C, immunoblotting of GABARAP family proteins and truncated GEC1. Immunoblotting of proteins at 40 h tal structures of GABARAP,
after transfection was conducted. Two hundred thousand cells in Laemmli sample buffer (per lane) were
loaded and resolved by 15% Tricine/SDS-PAGE. Proteins were detected by immunoblotting with polyclonal GATE-16, and MAP-LC3 showed
that the tubulin-binding domains
anti-GEC1 antibody, which cross-reacts with GABARAP and GATE16 in immunoblotting (14).
contain two helices (H1 and H2)
(28, 42, 43, 45– 47). The regions in
components. It is likely that the hydrophobic patches on all these proteins have high contents of basic residues, which
GABARAP and GATE-16 interact with the lipophilic FPXXM are thought to be important for binding to the highly acidic
C-terminal region of tubulin via ionic interaction (48). The
motif in the hKOPR C-tail in a similar manner.
The Y2H data revealed that Leu44 and Tyr109 of GEC1 were observations that GEC1-tubulin binding is salt-sensitive and
important for its interaction with the hKOPR C-tail (Fig. 4), is abolished in the presence of high salt (400 mM NaCl) are
which is likely because of their interaction (Fig. 7E) in maintain- consistent with the ionic nature of GEC1-tubulin interaction
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411 of the GABAA receptor ␥2 subunit, identified to be the
fragment interacting with GABARAP (16), does not contain
this sequence. Neither does the KOPR C-tail. These findings
further support the notion that hydrophobic interactions, not
specific amino acid sequences, are the main driving force for
GEC1 and GABARAP to bind their partners.
Conclusion—We have demonstrated that the residues critical for hKOPR binding form a curved hydrophobic patch on the
surface of GEC1, which interacts with FPXXM, and that hydrophobic interaction is the major force driving binding between
GEC1 and hKOPR C-tail. GEC1 is likely to bind to other molecules by hydrophobic interactions, even molecules without the
FPXXM sequence. Our study strongly suggests an expanding
set of GEC1-binding cell surface receptors and a broader functional importance than previously expected. Thus, GEC1 may
have chaperone-like effects for many molecules. GEC1 mRNA
has been shown to be up-regulated by estrogen (11, 53); therefore, GEC1 may be important in sex differences of some biological functions.
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